Lessons Learned from the Implementation of a Person-Centred Digital Health Platform in Cancer Care.

Saima Ahmed^1,2, Karine LePage², Renata Benc², Guy Erez³, Alon Litvin³, Annie Werbitt⁴, Gabrielle Chartier², Carly Berlin², Carmen G Loiselle^1,2,5,6

¹Division of Experimental Medicine, Faculty of Medicine and Health Sciences McGill University, Montreal, QC H4A 3J1, Canada.

²Centre Intégré Universitaire de Santé et de Services Sociaux (CIUSSS) du Centre-Ouest-de l'Île-de Montréal, Montreal, QC H3T 1E2, Canada.

³Belong.life Inc., New York, NY 10001, USA.

⁴Hope & Cope, Montreal, QC H3T 1E2, Canada.

⁵Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H4A 3T2, Canada.

⁶Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC H3A 2M7, Canada.

PubMed PMC DOI PDF

Abstract

The SARS-CoV-2 (COVID-19) pandemic has accelerated the development and use of digital health platforms to support individuals with health-related challenges. This is even more frequent in the field of cancer care as the global burden of the disease continues to increase every year. However, optimal implementation of these platforms into the clinical setting requires careful planning and collaborat…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.